Skip Navigation LinksHome > October 2013 - Volume 19 - Issue 5, Movement Disorders > The Ethics of Refusing a Request for Off-Label Deep Brain St...
CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000436162.25824.33
Ethical Perspectives

The Ethics of Refusing a Request for Off-Label Deep Brain Stimulation Currently in Clinical Trial

Fleming, James K. MD, MSc; Charles, David MD

Collapse Box

Abstract

Physicians must ensure that patients understand that the principal aim of research is to increase generalizable knowledge. However, patients may hope for individual benefit as a secondary goal of participation. Highly motivated patients may request treatment off label if trial enrollment has ended, leading to ethical dilemmas for clinicians. This case uses early deep brain stimulation (DBS) as an example for exploring the ethically relevant questions related to the off-label use of medical devices.

Copyright © 2013 by the American Academy of Neurology.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login